ArticlePharmaceuticals (Basel, Switzerland)2023

Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer's Disease.

Gabriela Dumitrita Stanciu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.